Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.46
-0.03 (-0.55%)
Jan 17, 2025, 4:00 PM EST - Market closed
Cytek Biosciences Employees
Cytek Biosciences had 676 employees as of December 31, 2023. The number of employees increased by 93 or 15.95% compared to the previous year.
Employees
676
Change (1Y)
93
Growth (1Y)
15.95%
Revenue / Employee
$297,648
Profits / Employee
-$15,030
Market Cap
703.31M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 676 | 93 | 15.95% |
Dec 31, 2022 | 583 | 81 | 16.14% |
Dec 31, 2021 | 502 | 111 | 28.39% |
Dec 31, 2020 | 391 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
CTKB News
- 11 days ago - Upgrading Cytek Biosciences Stock On An Upcoming Catalyst - Seeking Alpha
- 18 days ago - Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 21 days ago - Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025 - GlobeNewsWire
- 2 months ago - Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program - GlobeNewsWire
- 2 months ago - Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter - GlobeNewsWire
- 2 months ago - Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe - GlobeNewsWire